slides · global inventory
Traction
Slide type collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 10,471
Current window 5,191-5,220
Pages 350
Rows per page 30
Slide type
5,191-5,220 of 10,471
37
The slide highlights clinical response in specific patients, emphasizing normalization of mobility metrics.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
04
The slide uses a grid of big numbers to highlight growth and performance.Apollo Global Management | Investor Presentation Deck | 43 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
05
The slide uses a 3x3 grid of icons and metrics to present diverse company data points.Apollo Global Management | Investor Presentation Deck | 43 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
23
The slide highlights the growth trajectory of debt origination and categorizes the underlying platforms into three sectors: Commercial & Trade Finance, Equipment & Transportation, and Consumer & Residential.Apollo Global Management | Investor Presentation Deck | 43 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
24
The chart shows a clear upward trajectory from $252M in 2020 to a projected ~$500M in 2026E.Apollo Global Management | Investor Presentation Deck | 43 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
11
Data table includes standard error (SE) values for each mean. Footnote provides specific study parameters.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
12
The slide displays longitudinal data for cohorts E, F, I, J, G, and K, with specific callouts for individual patient outcomes.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
13
The slide displays 8 individual patient charts tracking three biomarkers over 64 weeks. Two patients (53 and 58) show NA retreatment periods.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
14
Data presented at EASL 2022. Shows longitudinal patient data for patients 42, 43, and 48.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
21
Includes a line chart for efficacy over time and two bar charts for pharmacokinetic concentrations in plasma vs liver.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
08
The slide includes a bar chart for revenue, a donut chart for revenue split, and a list of value drivers.Azerion | Investor Presentation Deck | 32 slides · Azerion
Pitch deck Investor relations Beat · Business Model1 hit
13
The slide categorizes reach into three segments: Non-game content (>400m), Game content (>100m), and E-commerce.Azerion | Investor Presentation Deck | 32 slides · Azerion
Pitch deck Investor relations Beat · Traction1 hit
18
The slide uses a process-style arrow graphic to represent integration progress.Azerion | Investor Presentation Deck | 32 slides · Azerion
Pitch deck Investor relations Beat · Traction1 hit
19
The slide uses a clear layout to contrast financial metrics with their corresponding strategic drivers.Azerion | Investor Presentation Deck | 32 slides · Azerion
Pitch deck Investor relations Beat · Traction1 hit
20
Includes a waterfall chart for cash conversion and a bridge chart for net debt.Azerion | Investor Presentation Deck | 32 slides · Azerion
Pitch deck Investor relations Beat · Traction1 hit
21
The slide uses two bar charts to illustrate operational and financial trends, paired with bulleted explanations.Azerion | Investor Presentation Deck | 32 slides · Azerion
Pitch deck Investor relations Beat · Traction1 hit
22
The slide uses a combination of a dual-axis combo chart for operational metrics and a grouped bar chart for financial performance.Azerion | Investor Presentation Deck | 32 slides · Azerion
Pitch deck Investor relations Beat · Traction1 hit
28
Includes specific metrics for Love Island villa (3m visits, 52 min avg time) and Habbo Avatars (11.6k items, 4.5k owners, 0.115 floor price, 6.1k volume).Azerion | Investor Presentation Deck | 32 slides · Azerion
Pitch deck Investor relations 1 hit
29
The slide uses a central donut chart for gender and monthly plays, surrounded by game icons and flanked by bar charts for age and geography.Azerion | Investor Presentation Deck | 32 slides · Azerion
Pitch deck Investor relations 1 hit
06
Slide includes a map visualization of global instrument installations and customer segment breakdown.Berkeley Lights | Investor Presentation Deck | 15 slides · PhenomeX
Pitch deck Investor relations 1 hit
09
The slide uses a value-chain style layout to demonstrate product efficacy across the drug development lifecycle.Berkeley Lights | Investor Presentation Deck | 15 slides · PhenomeX
Pitch deck Investor relations 1 hit
12
The slide uses a dark theme with a decorative abstract graphic in the top right corner. The recurring revenue chart is a simple bar chart, while the installed base chart is a stacked bar chart.Berkeley Lights | Investor Presentation Deck | 15 slides · PhenomeX
Pitch deck Investor relations Beat · Financials1 hit
13
The slide uses two stacked bar charts to illustrate cost reduction trends.Berkeley Lights | Investor Presentation Deck | 15 slides · PhenomeX
Pitch deck Investor relations Beat · Financials1 hit
11
Includes a waterfall plot for partial response and a spider plot for longitudinal tumor change.BioAtla | Investor Presentation Deck | 44 slides · BioAtla
Pitch deck Investor relations Beat · Market SizingLoop · Cost Of Inaction1 hit
12
Includes a spider plot for target lesion change and a Kaplan-Meier survival curve with a summary table.BioAtla | Investor Presentation Deck | 44 slides · BioAtla
Pitch deck Investor relations Beat · Market SizingLoop · Cost Of Inaction1 hit
13
Includes specific clinical trial design details (dosing regimens, patient counts, endpoints).BioAtla | Investor Presentation Deck | 44 slides · BioAtla
Pitch deck Investor relations Beat · Market SizingLoop · Cost Of Inaction1 hit
14
The slide uses a decision tree/process flow to map patient cohorts to clinical outcomes and subsequent trial progression.BioAtla | Investor Presentation Deck | 44 slides · BioAtla
Pitch deck Investor relations Beat · Market SizingLoop · Cost Of Inaction1 hit
15
Includes specific clinical trial data (N=73 and N=26) and detailed breakdown of specific adverse events like constipation, neuropathy, and diarrhea.BioAtla | Investor Presentation Deck | 44 slides · BioAtla
Pitch deck Investor relations Beat · Market SizingLoop · Cost Of Inaction1 hit
17
The chart is a classic waterfall plot used in oncology to show tumor shrinkage/growth.BioAtla | Investor Presentation Deck | 44 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
19
The chart highlights two specific cohorts (40% and 44% ORR) within a red box to emphasize efficacy in PD-1 failure populations.BioAtla | Investor Presentation Deck | 44 slides · BioAtla
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit